Abstract C020: Discovery of novel SMARCA2 degraders with synergistic activity against SMARCA4 and KRAS co-mutant tumors
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415452706
Cites:
Cited by:
Related to: